This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Cerenis Therapeutics Holding S.a.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Patrik Sauter: Innovator in Sphingolipid Synthesis
Introduction
Patrik Sauter, an innovative inventor based in Ettingen, Switzerland, has made significant contributions to the field of biochemistry through his work on sphingolipids. With a total of two patents to his name, Sauter is recognized for his advancements in the synthesis of these vital molecules.
Latest Patents
Sauter's latest patents focus on groundbreaking methods for the synthesis of sphingomyelins and dihydrosphingomyelins. These patents outline various techniques for producing sphingolipids, including sphingosines, dihydrosphingosines, ceramides, and dihydroceramides. The innovations present not only enhance the understanding of these important biological molecules but also pave the way for potential applications in pharmaceuticals and biotechnology.
Career Highlights
Patrik Sauter currently works at Cerenis Therapeutics Holding S.A., where he continues to push the boundaries of research in lipid synthesis. His work is instrumental in expanding the knowledge of sphingolipid functions and their implications in health and disease.
Collaborations
During his career, Sauter has collaborated with talented individuals such as Daniela Carmen Oniciu and Stefan Heckhoff. Together, they have contributed to advancing innovative research that strives to improve therapeutic options and enhance our understanding of complex biological processes.
Conclusion
In summary, Patrik Sauter stands out as a key figure in the innovation of sphingolipid synthesis. His patents not only demonstrate his expertise and dedication to biochemistry but also signify his commitment to driving advancements in the field. Through his work at Cerenis Therapeutics Holding S.A. and collaboration with esteemed colleagues, Sauter’s influence continues to grow, promising exciting developments ahead in therapeutic applications.